FBInvestor
Stocks / Regencell Bioscience Hldgs L
Institutional Ownership

Regencell Bioscience Hldgs L

CUSIP G7487R100ORDINARY SHARESQ1 2026

13D / 13G Filings
9
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
88.6%
Max % of class reported
Institutional Holders
31
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

9 filings · latest Jul 11, 2025

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Jul 11, 2025Regencell (Bvi) Limited13D/A88.6%SEC
2Mar 13, 2025Regencell (Bvi) Limited13D/A86.2%SEC
3Jul 26, 2022Regencell (Bvi) Ltd13D/A81.2%10.56MSEC
4May 16, 2022Regencell (Bvi) Ltd13D/A81.0%10.54MSEC
5Apr 4, 2022Regencell (Bvi) Ltd13D/A80.6%10.49MSEC
6Dec 30, 2021Regencell (Bvi) Ltd13D/A80.2%10.39MSEC
7Dec 15, 2021Digital Mobile Venture Ltd.13G7.6%988.9KSEC
8Nov 22, 2021Regencell (Bvi) Ltd13D/A79.8%10.34MSEC
9Jul 27, 2021Regencell (Bvi) Ltd13D81.8%10.34MSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Geode Capital Management, LLC415.6K$10.57M
2Marex Group PLC31.6K$803.6K
3Vident Advisory, LLC29.6K$752.4K
4Squarepoint Ops LLC26.6K$676.8K
5Ubs Group AG23.9K$607.4K
6Morgan Stanley20.1K$510.6K
7Bank Of America Corp /De/17.2K$436.7K
8State Street Corp11.9K$301.4K
9Legal & General Group PLC9.9K$251.8K
10Lpl Financial LLC8.6K$218.6K